Department of Hematology, Karolinska University Hospital
About Department of Hematology, Karolinska University Hospital
The Karolinska University Hospital is a teaching hospital affiliated with Karolinska Institutet in Stockholm, Sweden, with two major sites in the municipalities of Solna and Huddinge. The hospital network is the second largest in Sweden, after Sahlgrenska University Hospital.
There are 1,340 beds in Department of Hematology, Karolinska University Hospital.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Nordic MDS Group
3
Alexion
2
Nordic Lymphoma Group
2
Celgene
1
Celgene Corporation
1
Karolinska Institutet
1
Clinical Trials at Department of Hematology, Karolinska University Hospital
During the past decade, Department of Hematology, Karolinska University Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes
2003-06-01
2007-02-01
Completed
215
Study of Safety in Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated With Eculizumab
2004-12-01
2006-11-01
Completed
85
Extension Study of Eculizumab in Patients With Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH)
2005-05-01
2008-10-01
Completed
187
Lenalidomide in High-risk MDS and AML With Del(5q) or Monosomy 5
2007-10-01
2009-12-01
Completed
28
Evaluation of Azacitidine in Transfusion Dependent Patients With Low-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)
2010-01-01
2012-08-01
Completed
30
Study to Evaluate the Safety and Efficacy of Pomalidomide Monotherapy in Subjects With Refractory or Relapsed Refractory Multiple Myeloma
2011-03-01
2014-07-31
Completed
74
Mesenchymal Stromal Cells as Treatment of Chronic Graft-versus-host Disease
2011-08-01
2017-03-01
Terminated
11
Individual Molecular MRD Monitoring for MDS Patients After Allo-SCT
2016-08-01
2019-08-01
Unknown status
200
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Department of Hematology, Karolinska University Hospital" #1 sponsor was "Nordic MDS Group" with 3 trials, followed by "Alexion" with 2 trials
sponsored, "Nordic Lymphoma Group" with 2 trials sponsored, "Celgene" with 1 trials sponsored and "Celgene Corporation"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Hematology, Karolinska University Hospital"
#1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Region Stockholm" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Department of Hematology, Karolinska University Hospital
According to Clinical.Site data, the most researched conditions in "Department of Hematology, Karolinska University Hospital" are
"MDS" (2 trials), "AML" (1 trials), "Chronic Myelomonocytic Leukemia" (1 trials), "DLBCL" (1 trials) and "Diffuse Large B Cell Lymphoma" (1 trials). Many other conditions were trialed in "Department of Hematology, Karolinska University Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Department of Hematology, Karolinska University Hospital
Most popular intervention types in "Department of Hematology, Karolinska University Hospital" are "Drug" (8 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "eculizumab" (2 trials), "Acalabrutinib-rituximab in patients with untreated mantle cell lymphoma" (1 trials), "Azacitidine" (1 trials), "CC-5013" (1 trials) and "Erythropoetin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Department of Hematology, Karolinska University Hospital
The vast majority of trials in "Department of Hematology, Karolinska University Hospital" are
10 trials for "All" genders.
Clinical Trials Status at Department of Hematology, Karolinska University Hospital
Currently, there are NaN active trials in "Department of Hematology, Karolinska University Hospital".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Department of Hematology, Karolinska University Hospital,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Department of Hematology, Karolinska University Hospital, 1 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".